In the group of male controls (group 1), no mutations were detected in the coding sequence (CDS) and the intron-exon boundaries of the AR. In group 2 (molecular defined DSD diagnoses other than AIS), there were also no AR-CDS or intron-exon boundary mutations. The gene discussed is AR; the disease is androgen insensitivity syndrome.